We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
3 hedge funds and large institutions have $23.2M invested in Decoy Therapeutics in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 3 → 3 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
21% less capital invested
Capital invested by funds: $29.5M → $23.2M (-$6.29M)
Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$4.08M |
| 2 |
Primecap Management
Pasadena,
California
|
+$4.08M |
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.08M |
| 2 |
Jennison Associates
New York
|
-$1.73M |
| 3 |
Lazard Asset Management
New York
|
-$876K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$128K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$73K |